FDA Inspection 1179727 — Sircle Laboratories, L.L.C.

Sircle Laboratories, L.L.C. — FEI 3011772828

The FDA completed an inspection of Sircle Laboratories, L.L.C. on September 16, 2022 in Madison, MS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 16, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Madison, MS (United States)

Citations

IDCFRDescription
107921 CFR 211.22(a)Contract drug products--lack of responsibility
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
113321 CFR 211.25(a)GMP Training Frequency
194321 CFR 211.180(e)(1)Review of representative number of batches